ArticleTherapeutic advances in gastroenterology2026
Long-term real-world effectiveness and safety of mirikizumab in ulcerative colitis: 52-Week results from an expanded international two-center retrospective cohort study.
Asaf Levartovsky et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.